NasdaqGS:SIEN

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products to plastic surgeons in the United States. More Details


Snowflake Analysis

Limited growth with imperfect balance sheet.


Similar Companies

Share Price & News

How has Sientra's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: SIEN is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 10% a week.

Volatility Over Time: SIEN's weekly volatility has decreased from 18% to 10% over the past year.


Market Performance


7 Day Return

2.6%

SIEN

2.2%

US Medical Equipment

1.5%

US Market


1 Year Return

-33.4%

SIEN

20.0%

US Medical Equipment

22.3%

US Market

Return vs Industry: SIEN underperformed the US Medical Equipment industry which returned 19% over the past year.

Return vs Market: SIEN underperformed the US Market which returned 22.1% over the past year.


Shareholder returns

SIENIndustryMarket
7 Day2.6%2.2%1.5%
30 Day25.3%3.4%8.8%
90 Day66.2%8.8%10.8%
1 Year-33.4%-33.4%21.0%20.0%25.1%22.3%
3 Year-60.4%-60.4%76.0%71.5%49.5%39.6%
5 Year15.6%15.6%147.7%128.7%105.8%83.3%

Long-Term Price Volatility Vs. Market

How volatile is Sientra's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Sientra undervalued compared to its fair value and its price relative to the market?

15.48x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate SIEN's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate SIEN's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: SIEN is unprofitable, so we can't compare its PE Ratio to the US Medical Equipment industry average.

PE vs Market: SIEN is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate SIEN's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: SIEN is overvalued based on its PB Ratio (15.5x) compared to the US Medical Equipment industry average (4.4x).


Next Steps

Future Growth

How is Sientra forecast to perform in the next 1 to 3 years based on estimates from 8 analysts?

27.0%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: SIEN is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: SIEN is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: SIEN is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: SIEN's revenue (22.6% per year) is forecast to grow faster than the US market (10.2% per year).

High Growth Revenue: SIEN's revenue (22.6% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if SIEN's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has Sientra performed over the past 5 years?

-22.8%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: SIEN is currently unprofitable.

Growing Profit Margin: SIEN is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: SIEN is unprofitable, and losses have increased over the past 5 years at a rate of 22.8% per year.

Accelerating Growth: Unable to compare SIEN's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: SIEN is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (0.2%).


Return on Equity

High ROE: SIEN has a negative Return on Equity (-491.91%), as it is currently unprofitable.


Next Steps

Financial Health

How is Sientra's financial position?


Financial Position Analysis

Short Term Liabilities: SIEN's short term assets ($137.7M) exceed its short term liabilities ($57.2M).

Long Term Liabilities: SIEN's short term assets ($137.7M) exceed its long term liabilities ($102.5M).


Debt to Equity History and Analysis

Debt Level: SIEN's debt to equity ratio (355.3%) is considered high.

Reducing Debt: SIEN's debt to equity ratio has increased from 16.9% to 355.3% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: SIEN has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: SIEN has less than a year of cash runway if free cash flow continues to reduce at historical rates of 33.6% each year


Next Steps

Dividend

What is Sientra current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate SIEN's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate SIEN's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if SIEN's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if SIEN's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of SIEN's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.3yrs

Average management tenure


CEO

Ron Menezes

0.083

Tenure

Mr. Ron Menezes serves as President and Chief Executive Officer of Sientra, Inc. since November 10, 2020. Mr. Menezes served as President and General Manager at Almirall, LLC since August 23, 2017. Mr. Men...


Leadership Team

NamePositionTenureCompensationOwnership
Paul Little
CFO, Senior VP & Treasurer2.33yrsUS$958.60k0.10%
$ 282.8k
Charles Huiner
Consultant1.25yrsUS$1.00mno data
Jeffrey Nugent
0.083yrUS$3.02m0.40%
$ 1.1m
Keith Sullivan
Director & Advisor to MiraDry Business3.33yrsUS$521.60k0.44%
$ 1.2m
Caroline Van Hove
Executive Chair of Board of Directors0.083yrno datano data
Ron Menezes
President & CEO0.083yrno datano data
Jeffrey Jones
Vice President of Operationsno datano datano data
Deborah Bettencourt
Vice President of Human Resources & Corporate Administrationno datano datano data
Oliver Bennett
General Counsel and VP of Compliance & Legal2.92yrsno data0.056%
$ 155.8k
Kirk Gunhus
Senior Vice President of Worldwide Sales0.83yrno datano data
Lisa Rosas
Vice President of Marketingno datano datano data
Valerie Miller
VP & Corporate Controller2.75yrsno datano data

1.3yrs

Average Tenure

56yo

Average Age

Experienced Management: SIEN's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Keith Sullivan
Director & Advisor to MiraDry Business3.33yrsUS$521.60k0.44%
$ 1.2m
Caroline Van Hove
Executive Chair of Board of Directors0.083yrno datano data
Nicholas Simon
Lead Independent Director5.08yrsUS$210.00k0.11%
$ 316.3k
Kevin O'Boyle
Independent Director6.42yrsUS$190.00k0.14%
$ 405.6k
Mary Fisher
Independent Director1.92yrsUS$334.18k0.046%
$ 129.3k
Philippe Schaison
Independent Director3.83yrsUS$302.50k0.13%
$ 350.4k

3.6yrs

Average Tenure

60yo

Average Age

Experienced Board: SIEN's board of directors are considered experienced (3.6 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Sientra, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Sientra, Inc.
  • Ticker: SIEN
  • Exchange: NasdaqGS
  • Founded: 2003
  • Industry: Health Care Supplies
  • Sector: Healthcare
  • Market Cap: US$280.020m
  • Shares outstanding: 50.45m
  • Website: https://sientra.com

Number of Employees


Location

  • Sientra, Inc.
  • 420 South Fairview Avenue
  • Suite 200
  • Santa Barbara
  • California
  • 93117
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
SIENNasdaqGS (Nasdaq Global Select)YesCommon StockUSUSDOct 2014
S0ZDB (Deutsche Boerse AG)YesCommon StockDEEUROct 2014

Biography

Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products to plastic surgeons in the United States. It operates through two segments, Breast Products and miraDry. The comp...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/12/04 23:45
End of Day Share Price2020/12/04 00:00
Earnings2020/09/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.